A Cross-sectional Real-life Study of the Prevalence, Severity, and Determinants of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes Patients.

Quentin Binet Audrey Loumaye Michel P Hermans Nicolas Lanthier

Published in: Journal of clinical and translational hepatology (2023)

Simple bioclinical tools allowed routine triage of T2DM patients for MAFLD severity, with high adherence of high-risk patients to subsequent noninvasive exams.

Keyphrases

end stage renal disease
type diabetes
ejection fraction
newly diagnosed
chronic kidney disease
emergency department
cardiovascular disease
oxidative stress
patient reported outcomes
glycemic control
fatty acid